Strategies are reshaping biologics manufacturing by boosting speed, flexibility, and productivity without expanding ...

The next-generation platform integrates VectorBuilder’s regulatory-compliant gene delivery technology with MaxCyte’s clinically validated electroporation platform to enable robust, scalable, and ...

CGT upstream bioprocessing presents unique scale-up and monitoring challenges that differ fundamentally from conventional mAb ...

The US Food and Drug Administration (FDA) has released a final guidance document with immediate effect advising sponsors on chemistry, manufacturing, and controls (CMC) flexibilities for cell and gene ...

Between March 2022 and July 2025, we enrolled 28 patients with hematologic malignancies in this single-center phase II trial. The infusion of a matched single CB unit was followed by a target dose of ...

No, this isn’t science fiction. Real-life researchers taught a dish of roughly 200,000 living human brain cells to play the classic 1990s computer game “Doom.” Experts at Cortical Labs, an Australian ...

Manufacturing CAR T cell therapy—one of the most powerful weapons against certain blood cancers—has to date involved an elaborate process, through which doctors first extract a patient’s immune cells ...

Galapagos is planning to wind down its cell therapy business, completing a whiplash change that saw the biotech go from focusing on the modality to ditching it in six months. Belgium-based Galapagos ...

Despite finally opening a long-planned alternative to its old isolation cells this year, Oregon’s largest youth prison continues to use its 1950s-era Intervention Unit nicknamed the “dungeon” and has ...

The potential for these kinds of machines to reshape computer processing, increase energy efficiency, and revolutionize medical testing has scientists excited. But when do we consider these cells to ...